Safe Life and Triosyn Merge to Accelerate Products for Pandemic Flu and Bioterrorism
SAN DIEGO, Calif. — Safe Life Corp. and Triosyn Corp. have merged to create the most advanced provider of technologies to protect against viral microbial threats. The resulting company is now supported by extensive technical resources, an expansive portfolio of patents, and a proven executive team. Backed by funding from VantagePoint Venture Partners and a number of other investors, Safe Life will accelerate its execution in air filtration, wound management, paints and coatings, and the purification of fluids by delivering high-performance products that protect people and the environment from microbial contamination.
The combined company will operate under the name of Safe Life, and Triosyn has become a wholly owned subsidiary. Richard Jaffe is leading the Safe Life team as Chairman and Chief Executive Officer. Jaffe previously served as Chairman and Chief Executive Officer of SafeSkin Corporation, the leading global manufacturer of disposable latex gloves for professional healthcare and laboratory workers. SafeSkin, which was voted “Best Small Company in America” by Forbes in 1996, was purchased by Kimberly-Clark Corporation in 2000 and continues today as one of the world’s most trusted brands of personal protective equipment. John Metz, former President of Kimberly-Clark’s Professional Healthcare Division, will serve as President and Chief Operating Office, and CM Lee, former Managing Director of Asian Operations for SafeSkin, will be responsible for offshore manufacturing. Several other senior executives from SafeSkin and Kimberly-Clark have also joined the organization. Pierre Jean Messier, Founder of Triosyn Technology, will continue as President and Chief Executive Officer of Triosyn Corp. and will also serve as Vice Chairman and Chief Scientific Officer of Safe Life.
Safe Life’s first product is a facemask based on Triosyn’s novel antimicrobial technology that has been specifically designed to preserve health and business continuity in the face of pandemics, threats of bioterrorism and environmental disasters.
Vermont Senator Patrick Leahy said, “Domestic preparedness is a key issue whether for pandemic flu or an act of bioterrorism.” The World Bank estimates a severe avian flu pandemic among humans could cost the global economy $2 trillion, which represents approximately 5% of the world’s $40 trillion gross domestic product.
“Safe Life brings financial resources, global sales experience and a proven successful management team that will allow us to extend our technology into a diverse portfolio of products,” said Messier. “This merger combines the technology, capital and executive leadership to fully leverage the business we’ve established with federal contracts in the United States, Canada and United Kingdom.”
“The patented antimicrobial technology developed by Triosyn has been proven effective in independent research against a broad spectrum of microorganisms,” said Jaffe. “Our facemask is the only disposable respirator that was architected specifically to be effective against viruses, including the Avian Flu.”
“Safe Life is a company that can make a difference in protecting the world’s citizens through its advances in technology innovation, conscious design and large scale manufacturing capabilities,” said Stephan Dolezalek, Managing Director and co-head of the VantagePoint Venture Partners Healthcare Practice. “We look forward to working with the executive team to build this important company.”
About Safe Life
Safe Life Corporation is the most advanced provider of technologies to protect people and the environment from viral microbial contamination. In independent research, the company’s patented antimicrobial technology, Triosyn® resin, has been proven effective against a broad spectrum of microorganisms that cause diseases, including tuberculosis, SARS and the Avian Flu. This technology has been applied to a diverse portfolio of products in the areas of air filtration, wound management, paints and coatings, and the purification of fluids. Safe Life’s protective facemasks, sold worldwide under the brand name of Triosyn Disposable Respirators, were designed by an international team of microbiologists, toxicologists and chemists to preserve health and business continuity in the face of pandemics, threats of bioterrorism and environmental disasters. Safe Life is headquartered in San Diego, California with operations and engineering in Williston, Vermont and research and development facilities in Montreal, Canada.
More information is available online at www.safelifecorp.com.